| ADHD Directory |
| ADHD Printables |
| ADHD Guides |
| Expert Answers |
| ADHD News |
| Tools and Checklists |
| ADHD Topics A-Z |
| Book Reviews |
| Podcasts |
 |
| ADHD Groups |
| ADHD Discussions |
| ADHD Blogs |
| Share Your Story |
| E-Newsletters |
| ADHD Events |
| ADHD Videos |
|
| Subscribe |
| Give a Gift |
| Current Issue |
| Archives |
| Buy Back Issues |
| Buy Booklets |
| Customer Service |
| Contact Us |
| Advertise |
AstraZeneca to test Alzheimer's Drug for Adult ADHDAstraZeneca and Targacept will begin Phase II trials to see the effectiveness of an experimental drug in adults with ADHD. Tuesday June 10th - 1:42pm Filed Under:
ADD Meds: Dosing,
Nonstimulant ADHD Medications
A drug currently being developed by AstraZeneca and the biotech firm Targacept for the treatment of Alzheimer's and cognitive dysfunction in Schizophrenia has shown "compelling attentional effects." Because of these findings, the two companies will soon begin Phase II trials of the medication for adults with ADHD. The researchers hope to find the efficacy of two different dose strengths of the drug. The study will incorporate a crossover double-blind procedure in which each participant will get a placebo and each dosage of the medication at different times during the study. 
 |
|
Print
